BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 6457415)

  • 1. Conversion of Glu-plasminogen to plasmin by urokinase in the presence of tranexamic acid.
    Takada A; Takada Y
    Thromb Res; 1981 May; 22(4):437-43. PubMed ID: 6457415
    [No Abstract]   [Full Text] [Related]  

  • 2. Conversion of proteolytically modified form (Lys-form) of human plasminogen to plasmin by urokinase in the presence of tranexamic acid.
    Takada A; Takada Y
    Thromb Res; 1981 Aug 15-Sep 1; 23(4-5):411-9. PubMed ID: 6459659
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of tranexamic acid on the conversion of Glu-plasminogen I and II to its Lys-forms.
    Takada A; Takada Y
    Thromb Res; 1985 Oct; 40(2):171-9. PubMed ID: 2933845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition by tranexamic acid of the conversion of single-chain tissue plasminogen activator to its two chain form by plasmin: the presence on tissue plasminogen activator of a site to bind with lysine binding sites of plasmin.
    Takada A; Takada Y
    Thromb Res; 1989 Sep; 55(6):717-25. PubMed ID: 2551068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of tranexamic acid, cis-AMCHA, and 6-aminohexanoic acid on the activation rate of plasminogen by urokinase in the presence of clot.
    Takada A; Ohashi H; Matsuda H; Takada Y
    Thromb Res; 1979; 14(6):915-23. PubMed ID: 473126
    [No Abstract]   [Full Text] [Related]  

  • 6. Interaction of plasmin with alpha 2-macroglobulin and alpha 2-antiplasmin in the presence and absence of tranexamic acid.
    Takada A; Takada Y
    Thromb Res; 1980 Apr 1-15; 18(1-2):237-46. PubMed ID: 6157220
    [No Abstract]   [Full Text] [Related]  

  • 7. Zymogen-activation kinetics. Modulatory effects of trans-4-(aminomethyl)cyclohexane-1-carboxylic acid and poly-D-lysine on plasminogen activation.
    Petersen LC; Brender J; Suenson E
    Biochem J; 1985 Jan; 225(1):149-58. PubMed ID: 2579638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of the activation of Glu-plasminogen by urokinase in the simultaneous presence of tranexamic acid or fibrin.
    Takada A; Sugawara Y; Takada Y
    Haemostasis; 1989; 19(1):26-31. PubMed ID: 2920977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of dextran sulfate and tranexamic acid on the activation of plasminogen by urokinase.
    Takada Y; Takada A
    Thromb Res; 1979; 16(5-6):865-9. PubMed ID: 160629
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of tranexamic acid on fibrinolysis, fibrinogenolysis and amidolysis.
    Takada A; Makino Y; Takada Y
    Thromb Res; 1986 Apr; 42(1):39-47. PubMed ID: 3705023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enzymatic properties of plasmins converted from acid-treated and native Glu- and Lys-plasminogens by urokinase.
    Takada A; Takada Y
    Thromb Res; 1981 Mar; 21(6):593-601. PubMed ID: 6455775
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on the mechanism of the antifibrinolytic action of tranexamic acid.
    Hoylaerts M; Lijnen HR; Collen D
    Biochim Biophys Acta; 1981 Feb; 673(1):75-85. PubMed ID: 7193484
    [No Abstract]   [Full Text] [Related]  

  • 13. Activation pathway of glu-plasminogen to Lys-plasmin by urokinase.
    Takada A; Takada Y
    Thromb Res; 1982 Sep; 27(6):671-7. PubMed ID: 6129717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of omega-aminoacids and clot formation on the activation by urokinase of various plasminogen preparations.
    Takada A; Takada Y
    Thromb Res; 1980 Apr 1-15; 18(1-2):167-76. PubMed ID: 6773180
    [No Abstract]   [Full Text] [Related]  

  • 15. Positive regulation of activation of plasminogen by urokinase: differences in Km for (glutamic acid)-plasminogen and lysine-plasminogen and effect of certain alpha, omega-amino acids.
    Peltz SW; Hardt TA; Mangel WF
    Biochemistry; 1982 May; 21(11):2798-804. PubMed ID: 6212078
    [No Abstract]   [Full Text] [Related]  

  • 16. Initial plasmin-degradation of fibrin as the basis of a positive feed-back mechanism in fibrinolysis.
    Suenson E; Lützen O; Thorsen S
    Eur J Biochem; 1984 May; 140(3):513-22. PubMed ID: 6233145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assay of functional plasminogen in rat plasma applicable to experimental studies of thrombolysis.
    Bangert K; Thorsen S
    Thromb Haemost; 2000 Aug; 84(2):299-306. PubMed ID: 10959704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary-site binding of Glu-plasmin, Lys-plasmin and miniplasmin to fibrin.
    Suenson E; Thorsen S
    Biochem J; 1981 Sep; 197(3):619-28. PubMed ID: 6459779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tranexamic acid is an active site inhibitor of urokinase plasminogen activator.
    Wu G; Mazzitelli BA; Quek AJ; Veldman MJ; Conroy PJ; Caradoc-Davies TT; Ooms LM; Tuck KL; Schoenecker JG; Whisstock JC; Law RHP
    Blood Adv; 2019 Mar; 3(5):729-733. PubMed ID: 30814058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetic study of the effect of heparin on the amidase activity of trypsin, plasmin and urokinase.
    Yomtova VM; Stambolieva NA; Blagoev BM
    Thromb Haemost; 1983 Jun; 49(3):199-203. PubMed ID: 6224310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.